Two new drugs use antibodies to deliver radiation directly to the tumor cell.


Combines antibody with yttrium-90 for treatment of non-Hodgkin's lymphoma

Maker: IDEC Pharmaceuticals

Status: Recommended by FDA advisory panel on Sept. 11


Antibody combined with iodine-131, also for non-Hodgkin's

Maker: Corixa/GlaxoSmithKline

Status: Completed FDA application filing on Sept. 7

Before it's here, it's on the Bloomberg Terminal. LEARN MORE